Formation Bio

Formation Bio

Director/Senior Director of Asset Quality Assurance

Boston, MA; New York, NY · Director

Sponsorship not specified$178k-$232kDetected 23 days ago
GCPSparkFDA RegulatoryResearchAnimal StudiesLeadershipGxP

About the role

  • About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development.
  • The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others.
  • About the Position Formation Bio is an AI native Biotech company running drug development programs, and the Quality function here is built to match that operating model: lean, risk-calibrated, and embedded in asset decisions from day one.

Responsibilities

  • Embed Quality by Design (QbD): Partner with asset development teams upstream to integrate Quality by Design principles into clinical, nonclinical, and CMC development plans, including those leveraging AI-enabled technology and real-world data.
  • Risk & Opportunity Mapping: Proactively identify meaningful quality risks and opportunities within assigned Asset Pods and collaborate with technical and strategic subject matter experts to establish fit-for-purpose control and mitigation strategies.
  • Acquisition & Commercial Readiness: Drive the audit-readiness strategy to ensure assets transition seamlessly from development toward commercial launch or out-licensing.
  • Regulatory & Audit Intelligence: Interpret and apply global regulatory expectations (FDA, EMA, ICH) in digital and AI-accelerated environments, applying first-principles thinking to build fit-for-purpose, lean compliance frameworks for asset development and commercialization.
  • Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients.
  • Partner with asset development teams upstream to integrate Quality by Design principles into clinical, nonclinical, and CMC development plans, including those leveraging AI-enabled technology and real-world data.
  • Proactively identify meaningful quality risks and opportunities within assigned Asset Pods and collaborate with technical and strategic subject matter experts to establish fit-for-purpose control and mitigation strategies.
  • Drive the audit-readiness strategy to ensure assets transition seamlessly from development toward commercial launch or out-licensing.

Nice to have

  • You are fluent working with data-driven teams and comfortable leveraging automation and digital tools to maximize data value and process efficiency.
  • You have deep knowledge of the critical transitions an asset makes between preclinical and clinical phases through commercial or acquisition readiness, with well-rounded GxP proficiency across GLP, GCP, and GMP.
  • You have a proven track record of managing program-level risk management frameworks and successfully leading assets through major regulatory inflection points and strategic transactions.

Skills

  • lean, risk-calibrated, and embedded in asset decisions from day one.
  • This is a rare seat at the table where quality strategy directly shapes how assets move forward and get to patients.

Compensation

  • Director $177,500 - $232,000; Senior Director $235,000 - $307,000
  • Individual compensation is determined by several factors, including role scope, geographic location, and skills & experience.
  • Your offer will reflect where you fall within the range based on these considerations.
  • In addition to base salary, we offer equity, comprehensive benefits, and generous perks.
  • If the posted range doesn't match your expectations, we still encourage you to apply!
  • Where We Hire Formation Bio is prioritizing hiring in key hubs, primarily the New York City and Boston metro areas, with a hybrid model requiring 3 days per week in office.

Benefits

  • Our Vision for AI in Pharma
  • Assess the quality health of external target assets during due diligence, including data quality and reliability, compliance risks, and vendor footprint.
  • You apply first-principles thinking to bypass rigid compliance mentalities in favor of risk-benefit-based, agile problem solving.

Company info

  • Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials.
  • Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials.

Equal opportunity

  • Formation Bio is committed to building a diverse and inclusive team.
  • We are an equal opportunity employer and welcome candidates from all backgrounds.
  • All qualified applicants will receive consideration for employment without regard to race, color, creed, religion, national origin, ancestry, sex (including pregnancy, childbirth, breastfeeding, and related medical conditions), gender identity or expression, sexual orientation, age, disability, genetic information, marital status, military or veteran status, or any other characteristic protected by federal, state, or local law.
  • Equal Opportunity Formation Bio is committed to building a diverse and inclusive team.
Apply directly at Formation Bio →Create a free account for alerts like thisView Formation Bio immigration profile

This listing is sourced directly from Formation Bio's careers page and normalized into a canonical job model.